Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease

Lubor Goláň,1 Ozlem Goker-Alpan,2 Myrl Holida,3 Ikka Kantola,4 Mariusz Klopotowski,5 Johanna Kuusisto,6 Aleš Linhart,1 Jacek Musial,7 Kathleen Nicholls,8 Derlis Gonzalez-Rodriguez,9 Reena Sharma,10 Bojan Vujkovac,11 Peter Chang,12 Anna Wijatyk12 1First Faculty of Medicine, Depa...

Full description

Bibliographic Details
Main Authors: Goláň L, Goker-Alpan O, Holida M, Kantola I, Klopotowski M, Kuusisto J, Linhart A, Musial J, Nicholls K, Gonzalez-Rodriguez D, Sharma R, Vujkovac B, Chang P, Wijatyk A
Format: Article
Language:English
Published: Dove Medical Press 2015-07-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/evaluation-of-the-efficacy-and-safety-of-three-dosing-regimens-of-agal-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/evaluation-of-the-efficacy-and-safety-of-three-dosing-regimens-of-agal-peer-reviewed-article-DDDT

Similar Items